Altre lingue Agilent Technologies, Inc.

Azioni

A

US00846U1016

Attrezzatura medica

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 12/05/2025			Variaz. 5gg	Var. 1 gen.
115,55 ^USD	+8,06%		+6,63%	-13,99%

02/05	Agilent Technologies, Inc. annuncia le dimissioni di Henrick Ancher-Jensen, Vicepresidente senior, Presidente di Agilent, Order Fulfillment and Supply Chain, con effetto dal 1° giugno 2025.	CI
01/05	Agilent Technologies Inc. presenta il rivoluzionario Seahorse XF Flex Analyzer: una svolta nella ricerca sui tessuti e sugli organoidi 3D	CI

Altre lingue

Agilent Technologies, Inc. Announces Resignation of Henrick Ancher-Jensen, Senior Vice President, Agilent President, Order Fulfillment and Supply Chain, Effective as of June 1, 2025	02/05
Agilent Unveils Transformative Seahorse XF Flex Analyzer, Revolutionizing 3D Tissue and Organoid Research	02/05
Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research	01/05
Agilent Technologies Inc. Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research	01/05
Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025	24/04
Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025	24/04
Agilent Says Diagnostic Assay Gets European IVDR Certification in Gastric Cancer	17/04
Agilent Technologies - Receives European Ivdr Certification For Pd-L1 Ihc 22C3 Pharmdx	17/04
Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma	17/04
Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction Adenocarcinoma	17/04
Agilent to Announce Second-Quarter Fiscal Year 2025 Financial Results on May 28	16/04
Agilent Technologies : PFAS Investor Presentation	15/04
Agilent Technologies, Inc. Announces Resignation of Heidi Kunz as Member of the Board of Directors, Member of the Compensation Committee, and A Member of the Nominating/Corporate Governance Committee, Effective May 21, 2025	02/04
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval	24/03
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval	24/03
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval	24/03
CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025	20/03
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski	19/03
Declaration of Voting Results by Agilent Technologies	17/03
Agilent's Cancer Diagnostic Kit Receives EU Approval for Two New Indications	10/03
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications	10/03
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications	10/03
Agilent Presents 2025 Darlene Solomon Award to Henry Ford Health Researcher Dr. Daisy Unsihuay Vila	05/03
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on January 9, 2023.	03/03
Tranche Update on Agilent Technologies, Inc. (NYSE:A)'s Equity Buyback Plan announced on May 29, 2024.	03/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Agilent Technologies, Inc.

Azioni

A

US00846U1016

Attrezzatura medica

Altre lingue

Filtri